Vaccine Development

Jul 16, 2015
By BioPharm International Editors
GSK accelerates delivery timeline for US quadrivalent flu vaccine.
Jul 13, 2015
By BioPharm International Editors
The European Medicines Agency reviews the safety of human papillomavirus vaccines.
Jul 07, 2015
By BioPharm International Editors
The European Pharmacopoeia has incorporated new provisions to encourage the use of in-process quality control methods.
Jun 25, 2015
By BioPharm International Editors
IDT Biologika acquired Aeras' vaccine manufacturing facility, and the companies will work together on tuberculosis vaccine development.
Jun 25, 2015
By BioPharm International Editors
The divestment of Nimenrix and Mencevax was to satisfy regulatory clearances when GSK gained Novartis’ vaccines business in an asset swap in March 2015.
May 21, 2015
By BioPharm International Editors
Medicago's new production facility will make plant-based vaccines and therapeutics.
May 11, 2015
By BioPharm International Editors
A vaccine patch may eliminate the need for traditional means of vaccine distribution, according to an article in NPR.
Apr 20, 2015
By BioPharm International Editors
GSK notifies CDC and FDA that it is recalling the remaining doses of its 2014–2015 flu vaccine, Flulaval Quadrivalent Thimerosal-free Pre-Filled Syringes, due to decreased potency.
Apr 03, 2015
By BioPharm International Editors
GlaxoSmithKline announces global vaccines research and design facility to be based in Rockville, MD, USA.
Apr 02, 2015
By BioPharm International Editors
NIH announced positive safety results from the vaccine, VSV-ZEBOV, and found that all patients in the study experienced a strong antibody response.
native1_300x100
lorem ipsum